Key drivers for each region include: for North America, policies supporting research and development, demographics with a high prevalence of skin disorders, and ecosystem maturity with established healthcare systems. For Europe, drivers include adoption of innovative treatments, investments in research and development, and infrastructure with well-established healthcare systems. In Asia Pacific, drivers include demographics with a large and growing population, investments in healthcare infrastructure, and policies supporting healthcare development. For Latin America, drivers include adoption of new treatments, investments in healthcare infrastructure, and ecosystem maturity with growing healthcare systems. In Middle East & Africa, drivers include investments in healthcare infrastructure, policies supporting healthcare development, and demographics with a growing population.